首页|期刊导航|中国中医急症|风芍六君子汤干预急性重症溃疡性结肠炎机制的网络药理学与分子对接研究

风芍六君子汤干预急性重症溃疡性结肠炎机制的网络药理学与分子对接研究OA

Study on the Mechanism of Fengshao Liujunzi Decoction Intervening in Acute Severe Ulcerative Colitis Based on Network Pharmacology and Molecular Docking

中文摘要英文摘要

目的 基于网络药理学与分子对接技术,探寻风芍六君子汤干预急性重症溃疡性结肠炎(ASUC)的潜在作用机制,为其临床应用提供理论依据.方法 通过中药系统药理学数据库与分析平台(TCMSP)以及相关文献筛选风芍六君子汤的活性成分,并利用Swiss Target Prediction数据库预测其潜在作用靶点;采用人类孟德尔遗传联机系统(OMIM)、人类基因综合数据库(GeneCards)、疾病基因网络数据库(DisGeNet)和治疗靶点数据库(TTD)等收集ASUC相关疾病靶点.对药物靶点与疾病靶点进行交集分析,构建蛋白相互作用(PPI)网络以筛选关键成分和核心靶点.利用Metascape平台对交集靶点进行基因本体(GO)功能及京都基因和基因组数据库(KEGG)信号通路富集分析,并基于网络分析结果选取代表性活性成分与核心靶点进行分子对接验证.结果 风芍六君子汤共筛选获得183个活性成分,潜在作用靶点1 057个;获得ASUC相关靶点1 969个,取交集后得到446个潜在治疗靶点.PPI网络分析筛选出43个核心靶点,其中蛋白激酶B1(Akt1)、信号转导与转录激活因子3(STAT3)、肿瘤蛋白p53(TP53)、酪氨酸蛋白激酶(SRC)等处于网络核心位置.GO富集分析显示,相关靶点主要参与外源性刺激应答、蛋白修饰及细胞凋亡等生物学过程;KEGG富集分析提示靶点主要富集于磷脂酰肌醇3-激酶-蛋白激酶B信号通路(PI3K-Akt)、丝裂原活化蛋白激酶(MAPK)等炎症及免疫相关信号通路.分子对接研究结果显示,槲皮素、木犀草素和山柰酚与核心靶点具有较好的结合能力.结论 风芍六君子汤可能通过多成分、多靶点、多通路协同作用,调控炎症反应及肠黏膜损伤过程,从而干预ASUC的发生发展.本研究为风芍六君子汤用于ASUC治疗提供了一定的理论支持.

Objective:To explore the potential mechanism of Fengshao Liujunzi Decoction intervening in acute severe ulcerative colitis(ASUC)based on network pharmacology and molecular docking,so as to provide a theoreti-cal basis for its clinical application.Methods:The active components of Fengshao Liujunzi Decoction were screened through the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform(TC-MSP)and related literature,and the potential targets were predicted by Swiss Target Prediction database.ASUC-related disease targets were collected from Online Mendelian Inheritance in Man(OMIM),GeneCards,DisGeNeT and Therapeutic Target Database(TTD).The intersection of drug targets and disease targets was analyzed,and pro-tein-protein interaction(PPI)network was constructed to screen key components and core targets.Gene Ontology(GO)functional enrichment and Kyoto Encyclopedia of Genes and Genomes(KEGG)signaling pathway enrich-ment analyses of the intersection targets were performed using Metascape.Molecular docking verification was con-ducted between representative active components and core targets based on network analysis results.Results:A total of 183 active components and 1 057 potential targets of Fengshao Liujunzi Decoction were screened,and 1 969 ASUC-related targets were obtained,with 446 potential therapeutic targets obtained after intersection.PPI network analysis screened 43 core targets,among which Akt serine/threonine kinase 1(Akt1),signal transducer and activator of transcription 3(STAT3),tumor protein p53(TP53)and proto-oncogene tyrosine-protein kinase(SRC)were at the core position.GO enrichment analysis showed that the related targets were mainly involved in biological processes such as response to exogenous stimulus,protein modification and apoptosis.KEGG enrichment analysis indicated that the targets were mainly enriched in inflammation and immune-related signaling pathways including phosphatidylinositol 3-kinase-protein kinase B(PI3K-Akt)signaling pathway and mitogen-activated protein kinase(MAPK)signaling pathway.Molecular docking results showed that quercetin,luteolin and kaempfer-ol had good binding ability with core targets.Conclusion:Fengshao Liujunzi Decoction may regulate inflammatory response and intestinal mucosal injury through synergistic effects of multiple components,multiple targets and mul-tiple pathways,thereby intervening in the occurrence and development of ASUC.This study provides certain theo-retical support for the application of Fengshao Liujunzi Decoction in the acute phase of ASUC.

黄洁瑶;章文锦;毕晓飞;鲁洋博;李柏群;方伟;肖亚平;胡彦君

重庆大学附属三峡医院,重庆 404000重庆大学附属三峡医院,重庆 404000重庆大学附属三峡医院,重庆 404000重庆大学附属三峡医院,重庆 404000重庆大学附属三峡医院,重庆 404000重庆大学附属三峡医院,重庆 404000重庆大学附属三峡医院,重庆 404000重庆大学附属三峡医院,重庆 404000

医药卫生

急性重症溃疡性结肠炎风芍六君子汤网络药理学分子对接作用机制

Acute severe ulcerative colitisFengshao Liujunzi DecoctionNetwork pharmacologyMolecular dockingMechanism of action

《中国中医急症》 2026 (5)

497-502,510,7

国家自然科学基金项目(82405004)重庆市科卫联合中医药科研项目(2024ZYQN013)重庆市万州区科卫联合医学科研项目(wzstc-kw2023016)

10.3969/j.issn.1004-745X.2026.05.001

评论